| Issue |
Section |
Title |
File |
| No 5 (2013) |
Articles |
CURRENT APPROACHES TO PREVENTING OVARIAN HYPERSTIMULATION SYNDROME |
|
| No 11 (2017) |
Articles |
Sociomedical characteristics of HIV-infected patients in IVF programs |
|
| No 9 (2018) |
Articles |
Transdermal estrogens in assisted reproductive technology programs |
|
| No 9 (2019) |
Articles |
Cryopreservation of reproductive material in cancer patients |
|
| No 9 (2019) |
Articles |
Efficiency of maturation of oocytes obtained from cancer patients during ovariectomy |
|
| No 8 (2019) |
Articles |
PREPARATION FOR THE IN VITRO FERTILIZATION TREATMENT OF INFERTILITY IN DIMINISHED OVARIAN RESERVE- PRE-IVF TIDOR |
|
| No 11 (2020) |
Articles |
Ovarian protection before gonadotoxic therapy is a problem of oncology and reproductive medicine |
|
| No 11 (2020) |
Articles |
Characteristics and management of cancer patients who wish to preserve their reproductive capacity |
|
| No 1 (2021) |
Articles |
GENOTYPING OF EMBRYOS USING FRAGMENTAL STR ANALYSIS AFTER WHOLE GENOME AMPLIFICATION |
|
| No 11 (2020) |
Articles |
The use of aromatase inhibitors for rapid relief of ovarian hyperstimulation symptoms occurring with an in vitro fertilization program |
|
| No 11 (2021) |
Articles |
Search for the causes of reproductive system disorders: a research review |
|
| No 7 (2021) |
Articles |
Characteristics of folliculogenesis, steroidogenesis, and oogenesis during ovarian stimulation in the luteal phase of the menstrual cycle |
|
| No 11 (2021) |
Articles |
Fertility outcomes in women after therapy for non-Hodgkin lymphoma |
|
| No 9 (2022) |
Articles |
Analysis of the embryonic stage of in vitro fertilization programs in patients with unexplained infertility |
|
| No 5 (2022) |
Articles |
Clinical characteristics and embryological parameters in IVF programs for women with unexplained infertility |
|
| No 9 (2022) |
Articles |
The use of androgen priming in infertile women with diminished ovarian reserve undergoing assisted reproductive technology (IVF/ICSI) |
|
| No 6 (2022) |
Articles |
Indications and effectiveness of technique for immature oocyte-cumulus complexes retrieval from ovarian tissue followed by their in vitro maturation |
|
| No 6 (2022) |
Articles |
Embryo tranfer at zygote stage in patients with failed embryonic development in previous in vitro fertilization programs |
|
| No 9 (2022) |
Articles |
Experimental technique for the transfer of pronuclear stage genetic material |
|
| No 10 (2022) |
Articles |
Comparative study of the equivalence of the biosimilar follitropin alpha preparation (solution for subcutaneous injection) and the original follitropin alpha preparation (lyophilisate for preparation of solution for subcutaneous administration) in women with different responses to ovarian stimulation in an in vitro fertilization program: results of a phase IV clinical trial |
|
| No 5 (2022) |
Articles |
Birth of a healthy baby in a patient with diminished ovarian reserve after intraovarian autologous platelet-rich plasma injection and an in vitro fertilization program |
|
| No 11 (2022) |
Articles |
Development and validation of a questionnaire for assessing androgen deficiency in women (FAD - Female Androgen Deficiency) of reproductive age |
|
| No 1 (2022) |
Articles |
Molecular biological bases for intraovarian folliculogenesis, follicular maturation and recruitment |
|
| No 3 (2023) |
Original Articles |
Medical and social factors of infertility in Russia |
|
| No 6 (2023) |
Reviews |
New approaches to studying the regulation of preimplantation embryonic development |
|
| No 7 (2023) |
Original Articles |
Reproductive function of patients with lymphoproliferative diseases after completion of chemotherapy |
|
| No 8 (2023) |
Clinical Notes |
Progestogens safety in the treatment of infertility and during pregnancy: new data in 2023. Position of the Russian Society of Obstetricians and Gynecologists |
|
| No 9 (2023) |
Original Articles |
Reproductive function in patients with endocrine infertility |
|
| No 1 (2024) |
Reviews |
Extracellular vesicles derived from multipotent mesenchymal stromal cells: pathogenetic rationale for therapeutic use |
|
| No 2 (2024) |
Original Articles |
Clinical and laboratory characteristics of patients with embryonic arrest in the early embryonic period of in vitro fertilization programs |
|
| No 6 (2024) |
Original Articles |
Activation of ovarian function in patients with diminished ovarian reserve through administration of extracellular vesicles |
|
| No 8 (2024) |
Original Articles |
The effectiveness of programs of embryo cryo-transfer into the uterine cavity in women with overweight and obesity |
|
| No 8 (2024) |
Articles |
The safety of hormone therapy during pregnancy. Joint statement by experts in reproductive medicine, obstetrics and gynecology, endocrinology, clinical pharmacology, neonatology and pediatrics |
|
| No 9 (2024) |
Reviews |
Genetic factors of early embryo developmental arrest in in vitro fertilization programs |
|
| No 12 (2024) |
Original Articles |
Clinical use of expanded genetic testing in the management of couples with unexplained infertility |
|
| No 3 (2025) |
Original Articles |
Predictors of pregnancy rate in assisted reproductive technologies: results of the iris observational program in the population of Russia and Kazakhstan |
|
| No 4 (2025) |
Original Articles |
Use of in vitro fertilization programs to preserve reproductive material in patients with breast cancer |
|
| No 4 (2025) |
Original Articles |
The effect of myo-inositol on the follicular fluid metabolomic profile in women with predicted poor ovarian response undergoing in vitro fertilization: association with oocyte quality |
|
| No 6 (2025) |
Original Articles |
Assessment of embryological outcomes in IVF programs for patients of different age groups based on AMH levels |
|
| No 9 (2025) |
Reviews |
Chromosomal mosaicism in human embryos: a variant of normal development or pathology? |
|
| No 9 (2025) |
Original Articles |
Use of extracellular vesicles from multipotent mesenchymal stromal cells in preparation for in vitro fertilization programs in patients with diminished ovarian reserve |
|
| No 10 (2025) |
Articles |
Preservation of reproductive health as a basis for increasing birth rates. A joint position of experts in reproductive medicine, obstetrics and gynecology, endocrinology, and clinical pharmacology |
|
